• Pomalidomide (CC-4047): From Mechanism to Model

  2026-08-10

  A translational framework for using Pomalidomide (CC-4047) in multiple myeloma and broader hematological malignancy research, integrating tumor microenvironment modulation, genomic model selection, erythroid progenitor cell differentiation, and reproducible assay design.

• AM 281 for CB1 Mechanism Studies

  2026-08-09

  AM 281 provides a selective pharmacological handle for testing how CB1 activity shapes astrocytic GLT-1, CREB signaling, neuronal survival, and cognition after traumatic brain injury. This workflow-focused guide covers formulation, time-course design, behavioral controls, and troubleshooting for memory impairment research and related neuropharmacology applications.

• Azilsartan in Astrocyte–Microglia RAS Assays

  2026-08-08

  Azilsartan (TAK-536) provides a selective pharmacological way to test whether AT1 signaling links activated microglia with reactive astrocyte phenotypes. This practical guide translates RAS–SIRT3 findings into controlled conditioned-medium workflows, dosing strategies, and troubleshooting decisions for cardiovascular and neuroinflammation research.

• Rotigotine: From Dopamine Signaling to Bladder Assays

  2026-08-07

  Rotigotine is a dopamine D2/D3 receptor agonist with broad dopaminergic activity and neuroprotective potential. This article develops a route-aware framework for Parkinson’s disease research, showing how cystometry, receptor assays, and cell-based models can reveal effects that motor testing alone may miss.

• RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti

  2026-08-07

  Harper et al. (2025) reveal that cell death following RNA polymerase II (Pol II) inhibition is driven by an active signaling pathway, not passive loss of transcription. This finding redefines the mechanistic understanding of apoptosis in response to Pol II-targeting therapeutics and provides new directions for apoptosis assay design and cancer model refinement.

• 1-methyl Adenosine: Quantification, Mechanistic Roles & Tran

  2026-08-06

  Explore the critical roles and precise quantification of 1-methyl Adenosine in RNA modification research. This article reveals unique mechanistic insights and advances in assay technology, offering a distinct perspective for biomarker discovery and cancer metabolism studies.

• Azilsartan (TAK-536): Optimizing AT1 Blockade in RAS–SIRT3 R

  2026-08-06

  Azilsartan (TAK-536) empowers high-resolution dissection of the renin-angiotensin system and neuroinflammation, especially in astrocyte–microglia models. This guide translates new mechanistic insights into actionable protocols, troubleshooting, and comparative advantages for cardiovascular and CNS research.

• Brefeldin A: Strategic Tool for Translational ER Stress Rese

  2026-08-05

  Explore how Brefeldin A (BFA) bridges mechanistic insight and translational strategy by targeting ER stress, protein trafficking, and cancer apoptosis. This article guides advanced researchers through protocol optimization, competitive positioning, and future-ready perspectives, with evidence-based context and direct links to high-impact findings.

• Ibrexafungerp Efficacy Against Drug-Resistant Candida auris

  2026-08-05

  This study demonstrates that ibrexafungerp (MK 3118) maintains potent in vitro activity against fluconazole-resistant Candida auris and delivers significant in vivo efficacy in a delayed-therapy murine model of invasive candidiasis. These findings support ibrexafungerp as a valuable addition to the antifungal armamentarium for multidrug-resistant Candida infections.

• Optimizing Apoptosis and Ferroptosis Assays with Pifithrin-α

  2026-08-04

  This article delivers a scenario-driven, evidence-based guide for using Pifithrin-α (PFTα) (SKU A4206) in cell viability, apoptosis, and ferroptosis assays. Drawing on recent mechanistic insights and workflow challenges, it demonstrates how APExBIO’s high-quality Pifithrin-α supports reliable, reproducible inhibition of p53 pathways across neurotoxicity and cancer models.

• HBsAg Manipulation of TBK1: Suppressed Interferon, Induced A

  2026-08-04

  The referenced study uncovers how hepatitis B surface antigen (HBsAg) directly interacts with TANK-binding kinase 1 (TBK1), suppressing type I interferon production and initiating incomplete autophagy. These findings clarify the molecular strategies underpinning HBV persistence and offer new avenues for research into virus-host immune dynamics.

• Ertapenem Sodium Salt: Elevating Translational Resistance Re

  2026-08-03

  This thought-leadership article explores the mechanistic, experimental, and translational landscape of Ertapenem sodium salt in the context of Gram-positive and Gram-negative bacterial resistance. Drawing on recent epidemiological findings from Guangdong and practical workflow innovations, it provides strategic guidance for researchers seeking robust, reproducible antibiotic resistance models. The piece differentiates itself by bridging molecular pharmacology with protocol design, and by offering action-oriented insights that move beyond typical product summaries.

• Genistein for Cytoskeleton-Dependent Autophagy & Cancer Rese

  2026-08-03

  Leverage Genistein’s unique inhibition of tyrosine kinases to dissect cytoskeleton-driven autophagy and cell proliferation in cancer models. This guide bridges cutting-edge mechanotransduction research with optimized, actionable workflows and troubleshooting, empowering reproducible results in apoptosis and chemoprevention studies.

• L-Glutathione Reduced: Unveiling Mechanisms and Strategic Us

  2026-08-02

  Explore the scientific foundations and experimental strategies for using L-Glutathione Reduced as an antioxidant in advanced biomedical research. This article offers a unique mechanistic deep-dive into redox modulation and glutamine metabolism, setting it apart from existing guides.

• PDK4-IN-1 Hydrochloride: Precision PDK4 Inhibitor for Metabo

  2026-08-01

  PDK4-IN-1 hydrochloride delivers nanomolar potency and exceptional selectivity for dissecting mitochondrial energy metabolism in metabolic, cardiac, and tumor models. This guide translates recent breakthroughs into actionable protocols, advanced use-cases, and troubleshooting tips to maximize research impact with this APExBIO tool.

15686 records 1/1046 page Next 12345 下5页 Last page